PDLIM7 and cancer: The previously reported EBNA1‐targeting peptide sequence P4 (YFMVF‐GG‐RrRK; YFMVF, EBNA1 binding motif; RrRK, nucleus permeable motif) was combined with the FWLY motif for targeting the membrane LMP1; then the FWLY motif was engineered and placed at different sites: the C‐terminal side (P5: ‐Ahx‐YFMVFGGRrRKGGFWLY), (P6: ‐Ahx‐RrRKGGYFMVFGGFWLY), or the N‐terminal site (P7: ‐Ahx‐FWLYGGRrRKGGYFMVF) to evaluate the effect on killing EBV‐infected cancer cells.